Pericardial Effusion: Clinical Trials

1 trial for Pericardial Effusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Pericardial Effusion: new trials by email Literature Review of Pericardial Effusion trials Research Report on Pericardial Effusion

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
Paclitaxel, NOV-002, Carboplatin - Non Small Cell Lung Cancer
Phase 3CompletedCellectar Biosciences, Inc.9032006-11-012022-07-25

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Lung Diseases (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Albumin-Bound Paclitaxel (1)  ·  Carboplatin (1)  ·  NOV 002 (1)  ·  Paclitaxel (1)

Sponsors

Cellectar Biosciences, Inc. (1)

Countries

Canada (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Panos Fidias, MD (1)  ·  Thomas Lynch, MD (1)